Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.
BACKGROUND: Adjuvant chemotherapy (AC) in Stage II Colon Cancer (CC) is still under debate. Choice should be based on patients and disease characteristics. According to guidelines AC should be considered in high-risk T3N0 patients. No data are available for better option in low-risk patients. The ai...
Main Authors: | Roberta Grande, Domenico Corsi, Raffaello Mancini, Donatello Gemma, Fabrizio Ciancola, Isabella Sperduti, Lorena Rossi, Agnese Fabbri, Maria G Diodoro, Enzo Ruggeri, Germano Zampa, Sara Bianchetti, Teresa Gamucci |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3855068?pdf=render |
Similar Items
-
Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.
by: Roberta Grande, et al.
Published: (2016-01-01) -
Concurrent use of rabacfosadine and L‐asparaginase for relapsed or refractory multicentric lymphoma in dogs
by: Jacob R. Cawley, et al.
Published: (2020-03-01) -
Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study
by: Federica Lessi, et al.
Published: (2021-08-01) -
Azathioprine versus beta interferons for relapsing-remitting multiple sclerosis: a multicentre randomized non-inferiority trial.
by: Luca Massacesi, et al.
Published: (2014-01-01) -
A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
by: Gugliandolo A, et al.
Published: (2018-09-01)